Literature DB >> 23398243

Treatment of respiratory impairment in patients with motor neuron disease in the Netherlands: patient preference and timing of referral.

J Raaphorst1, J Tuijp, L Verweij, E J A Westermann, A J van der Kooi, M A Gaytant, L H van den Berg, M de Visser, M J Kampelmacher.   

Abstract

BACKGROUND AND
PURPOSE: We assessed the first evaluation at a large ventilation clinic in the Netherlands to: (i) determine what proportion of patients with motor neuron disease would benefit from earlier referral; and (ii) examine the patient preferences regarding ventilatory support.
METHODS: Observational study at a single centre with a catchment area of 7.6 million inhabitants. Data on disease status, the referral process and patients' preferences regarding ventilatory support were collected during the first home ventilation services (HVS) assessment and analysed for correlation with the presence of daytime hypercapnia and suspected nocturnal hypoventilation. The latter conditions require immediate (within 48 h) or subacute (within 3 weeks) initiation of ventilatory support.
RESULTS: Vital capacity (in percentage of predicted value, VC%pred) was assessed by referring physicians in 84% of the 217 referred patients; the mean VC%pred was 69% (SD 16). One-hundred and ninety-one patients attended the first HVS assessment without ventilatory support, at a median of 21 days following referral: 18% had respiratory failure (daytime hypercapnia), 19% had normocapnia but were suspected of nocturnal hypoventilation, and 63% had normocapnia without symptoms. Following the HVS assessment, 25 patients (13%) declined home mechanical ventilation; this occurred more often in patients with (14/70) compared with patients without respiratory impairment (11/121; P < 0.05).
CONCLUSION: A meaningful proportion of patients who desire ventilatory support are referred to a ventilation clinic after already developing respiratory failure. Future studies could examine means, including more sensitive respiratory measures, to detect those patients who could benefit from earlier referral.
© 2013 The Author(s) European Journal of Neurology © 2013 EFNS.

Entities:  

Keywords:  motor neuron disease; non-invasive ventilation; respiratory impairment; ventilatory support

Mesh:

Year:  2013        PMID: 23398243     DOI: 10.1111/ene.12096

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  6 in total

1.  Respiratory muscle training in late-onset Pompe disease: Results of a sham-controlled clinical trial.

Authors:  Harrison N Jones; Maragatha Kuchibhatla; Kelly D Crisp; Lisa D Hobson-Webb; Laura Case; Milisa T Batten; Jill A Marcus; Richard M Kravitz; Priya S Kishnani
Journal:  Neuromuscul Disord       Date:  2020-09-28       Impact factor: 4.296

2.  Comorbidity of dementia with amyotrophic lateral sclerosis (ALS): insights from a large multicenter Italian cohort.

Authors:  Francesca Trojsi; Mattia Siciliano; Cinzia Femiano; Gabriella Santangelo; Christian Lunetta; Andrea Calvo; Cristina Moglia; Kalliopi Marinou; Nicola Ticozzi; Gianluca Drago Ferrante; Carlo Scialò; Gianni Sorarù; Amelia Conte; Yuri M Falzone; Rosanna Tortelli; Massimo Russo; Valeria Ada Sansone; Adriano Chiò; Gabriele Mora; Barbara Poletti; Paolo Volanti; Claudia Caponnetto; Giorgia Querin; Mario Sabatelli; Nilo Riva; Giancarlo Logroscino; Sonia Messina; Antonio Fasano; Maria Rosaria Monsurrò; Gioacchino Tedeschi; Jessica Mandrioli
Journal:  J Neurol       Date:  2017-09-15       Impact factor: 4.849

3. 

Authors:  Harrison N Jones; Maragatha Kuchibhatla; Kelly D Crisp; Lisa D Hobson Webb; Laura Case; Milisa T Batten; Jill A Marcus; Richard M Kravitz; Priya S Kishnani
Journal:  Mol Genet Metab       Date:  2019-05-08       Impact factor: 4.797

4.  The predictive value of respiratory function tests for non-invasive ventilation in amyotrophic lateral sclerosis.

Authors:  T B M Tilanus; J T Groothuis; J M C TenBroek-Pastoor; T B Feuth; Y F Heijdra; J P L Slenders; J Doorduin; B G Van Engelen; M J Kampelmacher; J Raaphorst
Journal:  Respir Res       Date:  2017-07-25

5.  Peak expiratory flow is a reliably household pulmonary function parameter correlates with disease severity and survival of patients with amyotrophic lateral sclerosis.

Authors:  Qi-Jie Zhang; Jian-Chai Huang; Jia Chen; Wei Hu; Liu-Qing Xu; Qi-Fu Guo
Journal:  BMC Neurol       Date:  2022-03-19       Impact factor: 2.474

6.  The frontotemporal syndrome of ALS is associated with poor survival.

Authors:  Rosanne Govaarts; Emma Beeldman; Mike J Kampelmacher; Marie-Jose van Tol; Leonard H van den Berg; Anneke J van der Kooi; Peter J Wijkstra; Marianne Zijnen-Suyker; Nicolle A M Cobben; Ben A Schmand; Rob J de Haan; Marianne de Visser; Joost Raaphorst
Journal:  J Neurol       Date:  2016-09-26       Impact factor: 4.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.